Bappa Pharmaceutical Private Limited
About Bappa Pharmaceutical Private Limited
Data last updated:
Bappa Pharmaceutical Private Limited is a private limited company based in Lucknow, Uttar Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 20 February 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U85100UP2017PTC090616. Its GSTIN is 09AAHCB0797M1Z3 (Uttar Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors Shweta Nigam and Amit Krishna Srivastava.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Kh No – 164 Raypur Iim Road, Lucknow, Uttar Pradesh, India – 226025.
As per the financials filed for FY 2025, the company reported a revenue of ₹64.32 Lakh, a growth of 143% compared to the previous year. For the same year it recorded a net profit of ₹25,418 (net margin 0.4%) and EBITDA of ₹25,418 (EBITDA margin 0.4%). Revenue has grown at a compounded annual rate (CAGR) of 31% over three years and 39% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressKh No – 164 Raypur Iim Road, Lucknow, Uttar Pradesh, India – 226025
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Bappa Pharmaceutical Private Limited
The main business activity of Bappa Pharmaceutical is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Bappa Pharmaceutical Private Limited FY 2025 filings available
Bappa Pharmaceutical Private Limited reported revenue of ₹64.32 Lakh (up 143% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Bappa Pharmaceutical Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 39% over five years, including 143% growth in the latest year. EBITDA rose 103% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Bappa Pharmaceutical Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹25,418 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹25,418 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Bappa Pharmaceutical Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.4% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.4% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Bappa Pharmaceutical are in the company report.
Financial statements from FY 2017
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Bappa Pharmaceutical Private Limited
Bappa Pharmaceutical Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Wholesale Trading). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Healthyline Lifesciences Private Limited | ₹64.33 Lakh (FY 2025) | •••• | •••• | -69.0% | •••• | Delhi, India |
| Virat Vanijya Private Limited | ₹64.32 Lakh (FY 2025) | •••• | •••• | 0.0% | •••• | Kolkata, West Bengal, India |
| Fine Vectors Private Limited | ₹64.32 Lakh (FY 2025) | •••• | •••• | 187.0% | •••• | Bangalore, Karnataka, India |
| Usha Shriram Enterprises Private Limited | ₹64.32 Lakh (FY 2025) | •••• | •••• | -24.0% | •••• | New Delhi, Delhi, India |
| Sleepwell Enterprises Private Limited | ₹64.32 Lakh (FY 2025) | •••• | •••• | -41.0% | •••• | New Delhi, Delhi, India |
| Bappa Pharmaceutical Private Limited this company | ₹64.32 Lakh (FY 2025) | •••• | •••• | 143.0% | •••• | Lucknow, Uttar Pradesh, India |
| Dang Exim Private Limited | ₹64.31 Lakh (FY 2024) | •••• | •••• | -38.0% | •••• | Kolkata, West Bengal, India |
| Shreenath Peb Steel Structure Private Limited | ₹64.3 Lakh (FY 2024) | •••• | •••• | 22.0% | •••• | Indore, Madhya Pradesh, India |
| Prestokam India Private Limited | ₹64.3 Lakh (FY 2022) | •••• | •••• | -18.0% | •••• | Beur, Phulwari, Bihar, India |
| Farmer Leaf Krishi Producer Company Limited | ₹64.29 Lakh (FY 2024) | •••• | •••• | 144.0% | •••• | Baran, Rajasthan, India |
| Vrfor Limbcare Private Limited | ₹64.29 Lakh (FY 2024) | •••• | •••• | 200.0% | •••• | Thane, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Bappa Pharmaceutical by revenue in the same principal business activity (Wholesale Trading), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Bappa Pharmaceutical Private Limited
Bappa Pharmaceutical has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shweta Nigam | Director | 20 Feb 2017 | 9 Years 7 Months | Current |
| Amit Krishna Srivastava | Director | 20 Feb 2017 | 9 Years 7 Months | Current |
Ownership and Shareholding of Bappa Pharmaceutical Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Bappa Pharmaceutical Private Limited
Bappa Pharmaceutical Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Bappa Pharmaceutical Private Limited
Employment history and EPFO contributions of people linked to Bappa Pharmaceutical.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Bappa Pharmaceutical Private Limited
Bappa Pharmaceutical Private Limited has 2 board changes on record since 2017: 2 appointments. The latest: Amit Krishna Srivastava was appointed as Director on 20 Feb 2017.
Credit Ratings, Litigation & Regulatory Alerts for Bappa Pharmaceutical Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Bappa Pharmaceutical Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Bappa Pharmaceutical Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Bappa Pharmaceutical Private Limited
Bappa Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAHCB0797M1Z3 | Uttar Pradesh | Active | 14 Sep 2019 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Bappa Pharmaceutical Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bappa Pharmaceutical Private Limited
Bappa Pharmaceutical is an active private limited company based in Lucknow, Uttar Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 20 February 2017 (9+ years old) and is registered under CIN U85100UP2017PTC090616.
Bappa Pharmaceutical reported revenue of ₹64.32 Lakh for FY 2025 (up 143% YoY).
Bappa Pharmaceutical has 2 current directors:
- Shweta Nigam - Director
- Amit Krishna Srivastava - Director
Bappa Pharmaceutical reported a net profit of ₹25,418 (net margin 0.4%) and EBITDA of ₹25,418 (EBITDA margin 0.4%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Bappa Pharmaceutical is 31% over three years and 39% over five years. In the latest year (FY 2025) revenue rose 143%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Bappa Pharmaceutical is 09AAHCB0797M1Z3, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Bappa Pharmaceutical is U85100UP2017PTC090616. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Bappa Pharmaceutical was incorporated on 20 February 2017, making it 9+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The peers of Bappa Pharmaceutical by revenue are Healthyline Lifesciences Private Limited, Virat Vanijya Private Limited, Fine Vectors Private Limited, Usha Shriram Enterprises Private Limited, Sleepwell Enterprises Private Limited and 5 more, all in the same principal business activity (Wholesale Trading).
Amit Krishna Srivastava was appointed as Director on 20 Feb 2017. Shweta Nigam was appointed as Director on 20 Feb 2017.
The registered office of Bappa Pharmaceutical is at Kh No – 164 Raypur Iim Road, Lucknow, Uttar Pradesh, India – 226025.